The transporter associated with antigen processing (TAP) plays a critical role in peptide delivery, and cancer cells can modulate TAP1 and/or TAP2 levels to reduce peptide delivery, thereby evading recognition by cytotoxic CD8+ T cells (El Hage, Durgeau & Mami-Chouaib, 2013). This evidence concerns the gene TAP1 and cancer.